Published • loading... • Updated
Nigerian Drugmaker Fidson Selected to Manufacture Generic Influenza Antiviral Under Global Licence
Fidson joins 11 manufacturers in nine countries to produce generic baloxavir for 129 markets under a voluntary Roche licence, the company said.
4 Articles
4 Articles
Fidson wins Roche-backed licence to make generic influenza drug for 129 countries
Fidson Healthcare Plc, a Nigerian pharmaceutical manufacturer, has been selected by the Medicines Patent Pool (MPP) as one of 11 read more Fidson wins Roche-backed licence to make generic influenza drug for 129 countries
·Lagos, Nigeria
Read Full Article
Fidson selected as regional sublicensee to expand access to influenza treatment and strengthen pandemic preparedness
Fidson joins manufacturers across Brazil, China, India, Indonesia, Malaysia, Uganda, Ukraine and Vietnam under sublicence agreements to develop and manufacture generic versions of Roche’s baloxavir marboxil through MPP’s voluntary licence, supporting diversified manufacturing capacity and stronger pandemic preparedness. The leading pharmaceutical manufacturing company in Nigeria, Fidson Healthcare Plc has been selected as one of eleven […]
Coverage Details
Total News Sources4
Leaning Left1Leaning Right1Center1Last UpdatedBias Distribution34% Left, 33% Center, 33% Right
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
34% Left
L 34%
C 33%
R 33%
Factuality
To view factuality data please Upgrade to Premium
